Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
or

Forte Biosciences Inc (FBRX)

Forte Biosciences Inc (FBRX)
5.10 x 10 6.35 x 2
Post-market by (Cboe BZX)
6.05 -0.80 (-11.68%) 04/23/25 [NASDAQ]
5.10 x 10 6.35 x 2
Post-market 6.05 unch (unch) 16:00 ET
Quote Overview for Wed, Apr 23rd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
4.90
Day High
7.18
Open 7.18
Previous Close 6.85 6.85
Volume 55,700 55,700
Avg Vol 32,530 32,530
Stochastic %K 56.81% 56.81%
Weighted Alpha -87.22 -87.22
5-Day Change +0.21 (+3.60%) +0.21 (+3.60%)
52-Week Range 4.11 - 28.68 4.11 - 28.68
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 45,085
  • Shares Outstanding, K 6,582
  • Annual Sales, $ 0 K
  • Annual Income, $ -35,480 K
  • EBIT $ -37 M
  • EBITDA $ -37 M
  • 60-Month Beta 2.52
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.85

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.89
  • Number of Estimates 2
  • High Estimate -0.83
  • Low Estimate -0.95
  • Prior Year -4.00
  • Growth Rate Est. (year over year) +77.75%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.90 +23.47%
on 04/23/25
Period Open: 8.17
9.33 -35.16%
on 03/24/25
-2.12 (-25.95%)
since 03/21/25
3-Month
4.90 +23.47%
on 04/23/25
Period Open: 15.88
16.41 -63.12%
on 01/31/25
-9.83 (-61.90%)
since 01/23/25
52-Week
4.11 +47.20%
on 11/01/24
Period Open: 18.47
28.68 -78.91%
on 12/06/24
-12.41 (-67.24%)
since 04/23/24

Most Recent Stories

More News
5 Stocks Retail Investors Are Most Bullish On At Mid-Day

Retailers went overboard about a couple of biotech stocks and a MedTech name, among others on Wednesday.

FBRX : 6.05 (-11.68%)
QSI : 1.1700 (+3.54%)
DUOT : 6.14 (+4.07%)
IBB : 122.00 (+1.30%)
SLXN : 1.0300 (+46.51%)
SPY : 535.42 (+1.55%)
XBI : 79.10 (+1.88%)
ZIM : 13.77 (+5.76%)
Forte Biosciences Stock More Than Doubles On Oversubscribed $53M Private Placement: Retail Goes Wild

The funds will support clinical development of FB102, Forte’s proprietary anti-CD122 monoclonal antibody targeting autoimmune and autoimmune-related diseases.

FBRX : 6.05 (-11.68%)
VXF : 165.44 (+1.85%)
VTI : 263.44 (+1.70%)
ONEQ : 65.62 (+2.32%)
MindMed Sends Letter to Shareholders Highlighting Company’s Positive Momentum and Value-Enhancing Strategy

The Board of Directors (the “Board”) of Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED) (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product...

FBRX : 6.05 (-11.68%)
JAZZ : 104.19 (+0.78%)
MMED.NE : 14.9000 (+9.48%)
ALC : 93.70 (+0.42%)
INCY : 58.00 (+1.08%)
SGEN : 228.74 (-0.07%)
MNMD : 6.11 (+5.34%)
PFE : 22.39 (-0.62%)
MindMed Files Preliminary Proxy Statement for 2023 Annual Meeting

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders,...

FBRX : 6.05 (-11.68%)
MMED.NE : 14.9000 (+9.48%)
INCY : 58.00 (+1.08%)
SGEN : 228.74 (-0.07%)
MNMD : 6.11 (+5.34%)
BMY : 48.53 (-2.59%)
Forte Biosciences, Inc. Announces Full Year 2022 Results and Provides Business Update

Forte Biosciences, Inc. ( www.fortebiorx.com ) (NASDAQ: FBRX), a biopharmaceutical company focused on autoimmune diseases, today announced full year 2022 results and provided a business update.

FBRX : 6.05 (-11.68%)
Mr. David Gryska Appointed to Forte Biosciences Board of Directors

Forte Biosciences, Inc. ( www.fortebiorx.com ) (NASDAQ: FBRX), announced today that Mr. David Gryska has been appointed to the Forte Biosciences Board of Directors.

FBRX : 6.05 (-11.68%)
Forte Biosciences, Inc. Announces Third Quarter 2022 Results and Provides Business Update

Forte Biosciences, Inc. ( www.fortebiorx.com ) (NASDAQ: FBRX), a biopharmaceutical company focused on autoimmune diseases, today announced third quarter 2022 results and provided a business update.

FBRX : 6.05 (-11.68%)
Dr. Scott Brun, M.D. Appointed to Forte Biosciences Board of Directors

Forte Biosciences, Inc. ( www.fortebiorx.com ) (NASDAQ: FBRX), announced today that Dr. Scott Brun, M.D. has been appointed to the Forte Biosciences Board of Directors.

FBRX : 6.05 (-11.68%)
Camac Partners Condemns Forte Biosciences’ Seemingly Defensive and Unjustifiable Capital Raise

Camac Partners, LLC (together with its affiliates, "Camac" or “we”), which is one of the largest shareholders of Forte Biosciences, Inc. (Nasdaq: FBRX) (“Forte” or the “Company”), today expressed...

FBRX : 6.05 (-11.68%)
Forte Biosciences, Inc. Announces Second Quarter 2022 Results and Provides Business Update

Forte Biosciences, Inc. ( www.fortebiorx.com ) (NASDAQ: FBRX), a biopharmaceutical company focused on autoimmune diseases, today announced second quarter 2022 results and provided a business update.

FBRX : 6.05 (-11.68%)

Business Summary

Forte Biosciences Inc. is a clinical stage, dermatology company. It engages in developing biotherapeutic, FB-401, for the treatment of inflammatory skin diseases which is in clinical stage. Forte Biosciences Inc., formerly known as Tocagen Inc., is based in Sherman Oaks, California.

See More

Key Turning Points

3rd Resistance Point 9.47
2nd Resistance Point 8.32
1st Resistance Point 7.19
Last Price 6.05
1st Support Level 4.91
2nd Support Level 3.76
3rd Support Level 2.63

See More

52-Week High 28.68
Fibonacci 61.8% 19.29
Fibonacci 50% 16.40
Fibonacci 38.2% 13.50
Last Price 6.05
52-Week Low 4.11

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective